This white paper explores the most common electromagnetic compatibility (EMC) deficiencies that delay FDA 510(k) clearance for electrically powered medical devices. While standards such as IEC 60601-1-2 are well established, many submissions encounter review delays due to incomplete immunity testing, poorly defined essential performance, misaligned risk documentation, uncontrolled post-test design changes, and inconsistent labeling.
Drawing on decades of EMC engineering and regulatory experience, the paper explains how the FDA evaluates EMC data within the broader safety and effectiveness framework. It provides practical guidance on developing robust EMC test plans, aligning risk management with immunity results, addressing test failures through engineering mitigation, and maintaining traceability across documentation.
The goal is to help medical device manufacturers proactively reduce review cycles, avoid costly retesting, and accelerate time to market by integrating EMC strategy early in product development.
